The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for Lymphoma.

Saved in:
Bibliographic Details
Title: The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for Lymphoma.
Authors: Andersen L; Department of Biobehavioral Health Sciences, School of Nursing, The University of Pennsylvania, Philadelphia, PA. Electronic address: lucander@upenn.edu., Baker KM; Department of Biobehavioral Health Sciences, School of Nursing, The University of Pennsylvania, Philadelphia, PA., Difilippo H; Cell Therapy and Transplant Program, Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA., Meghani SH; Department of Biobehavioral Health Sciences, School of Nursing, The University of Pennsylvania, Philadelphia, PA., Porter D; Cell Therapy and Transplant Program, Abramson Cancer Center at the University of Pennsylvania, and Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA., Deng J; Department of Biobehavioral Health Sciences, School of Nursing, The University of Pennsylvania, Philadelphia, PA.
Source: Seminars in oncology nursing [Semin Oncol Nurs] 2024 Apr; Vol. 40 (2), pp. 151614. Date of Electronic Publication: 2024 Mar 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 8504688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3449 (Electronic) Linking ISSN: 07492081 NLM ISO Abbreviation: Semin Oncol Nurs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-3449
DOI:10.1016/j.soncn.2024.151614